Novartis Patient Support is dedicated to helping your patients get the assistance they need while receiving treatment. Enroll PATIENTS via fax Get patients enrolled in Novartis Patient Support with dedicated guidance about insurance, financial, and coding & billing support. Simply download the Start Form...
Novartis believes that medicines should be available to all who need them. We have a variety of programs to help support patients and make it easier for them to afford their medicines.
In, EffectivenessSupport, PatientStrategy, MitigationBermangorvine, By Martin
Financial Assistance Medication Adherence Support Bridge Program TASCENSO Time Program (baseline assessments and first dose observations) Find out more Product TASCENSO ODT is the same proven fingolimod you might be familiar with, but it comes in a unique orally disintegrating tablet formulation.1 Uniqu...
In the section “Editorial Assistance” it has been mistakenly stated that the funding for the assistance was provided by Sanofi instead of Novartis Pharma AG. References Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, et al. Tisagenlecleucel in adult relapsed or refr...
Medical Writing, Editorial, and Other Assistance The authors also acknowledge Helen Barham PhD (The Text Doctor) for writing support and Jenna Zan (Zed, Oxford) for creating the figures.Funding This research was funded by, and the Raid service fee was paid by Kyowa Kirin Services Ltd. Author...
Medical writing and editorial assistance was funded by Exelixis, Inc. (Alameda, CA) Acknowledgments Editorial and medical writing assistance were provided by Karen O’Leary, PhD, and Michael Raffin (Fishawack Communications Inc., Conshohocken, PA). ...
The NLA Expert Panel wishes to express its gratitude to the following individuals, whose assistance was invaluable in preparation of these recommendations: Mary R. Dicklin, PhD (Midwest Center for Metabolic & Cardiovascular Research), Ryan J. Essegian, Esq. (NLA), Lindsay Hart (NLA), and Chri...
Garcia (bio-graphics scientific visualization, Barcelona, Spain) for assistance with preparation of Fig. 3, and V. Hope Goldstein (Dana-Farber Cancer Institute, Boston, MA) for editorial assistance. Author information Author notes These authors contributed equally: Sara M. Tolaney, Aleix Prat. ...
Karen Munro, PhD, Quintiles, Reading, England, and Diane Kwiatkoski, PhD, Quintiles, Parsippany, New Jersey, provided medical writing assistance and prepared the first draft for the authors to edit, which was funded by ThromboGenics NV. All received compensation as employees from their lis...